Bosutinib Inhibits EGFR Activation in Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, and although new therapeutic approaches have been recently evaluated, overall patient survival is still poor. Thus, new effective and selective clinical treatments are urgently needed. An analysis of data from l...

Descripción completa

Detalles Bibliográficos
Autores principales: Segrelles, Carmen, Contreras, David, Navarro, Elena M., Gutiérrez-Muñoz, Carmen, García-Escudero, Ramón, Paramio, Jesús M., Lorz, Corina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073167/
https://www.ncbi.nlm.nih.gov/pubmed/29933569
http://dx.doi.org/10.3390/ijms19071824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073167/
https://www.ncbi.nlm.nih.gov/pubmed/29933569
http://dx.doi.org/10.3390/ijms19071824

Ejemplares similares